Background: Early detection and accurate diagnosis of pulmonary nodules are crucial for improving patient outcomes. While surgical resection of malignant nodules is still the preferred treatment option, it may not be feasible for all patients. We aimed to discuss the advances in the treatment of pulmonary nodules, especially stereotactic body radiotherapy (SBRT) and interventional pulmonology technologies, and provide a range of recommendations based on our expertise and experience. Summary: Interventional pulmonology is an increasingly important approach for the management of pulmonary nodules. While more studies are needed to fully evaluate its long-term outcomes and benefits, the available evidence suggests that this technique can provide a minimally invasive and effective alternative for treating small malignancies in selected patients. We conducted a systematic literature review in PubMed, designed a framework to include the advances in surgery, SBRT, and interventional pulmonology for the treatment of pulmonary nodules, and provided a range of recommendations based on our expertise and experience. Key Messages: As such, alternative therapeutic options such as SBRT and ablation are becoming increasingly important and viable. With recent advancements in bronchoscopy techniques, ablation via bronchoscopy has emerged as a promising option for treating pulmonary nodules. This study reviewed the advances of interventional pulmonology in the treatment of peripheral lung cancer patients that are not surgical candidates. We also discussed the challenges and limitations associated with ablation, such as the risk of complications and the potential for incomplete nodule eradication. These advancements hold great promise for improving the efficacy and safety of interventional pulmonology in treating pulmonary nodules.

This study provides an overview of the advancements in interventional pulmonology for the treatment of peripheral lung cancer patients. The challenges and limitations associated with ablation are also discussed, including the precise localization of lung nodules, evaluation of the ablation range under bronchoscopic guidance (due to the uncertainty in the dose-response relationship of energy conduction in lung tissue), reaching lung nodules without bronchial signs, replacing ablation catheters to increase the ablation range, as well as the risks of complications and potential residual mass formation. These advanced techniques have significant potential to enhance the efficacy and safety of interventional pulmonology in treating lung nodules. In summary, interventional pulmonology is becoming an increasingly important approach for managing lung nodules. While further research is needed to comprehensively evaluate its long-term effects and advantages, existing evidence suggests that this technology can provide a minimally invasive and effective alternative treatment method for selected patients with small malignant lung tumors.

1.
Sung
H
,
Ferlay
J
,
Siegel
RL
,
Laversanne
M
,
Soerjomataram
I
,
Jemal
A
, et al
.
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
.
CA Cancer J Clin
.
2021
;
71
(
3
):
209
49
. .
2.
The
L
.
Lung cancer: some progress, but still a lot more to do
.
Lancet
.
2019
;
394
(
10212
):
1880
. .
3.
Baldwin
D
,
O’Dowd
E
,
Tietzova
I
,
Kerpel-Fronius
A
,
Heuvelmans
M
,
Snoeckx
A
, et al
.
Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard
.
Eur Respir J
.
2023
;
61
(
6
):
2300128
. .
4.
Herth
FJ
,
Eberhardt
R
,
Sterman
D
,
Silvestri
GA
,
Hoffmann
H
,
Shah
PL
.
Bronchoscopic transparenchymal nodule access (BTPNA): first in human trial of a novel procedure for sampling solitary pulmonary nodules
.
Thorax
.
2015
;
70
(
4
):
326
32
. .
5.
Lederlin
M
,
Revel
MP
,
Khalil
A
,
Ferretti
G
,
Milleron
B
,
Laurent
F
.
Management strategy of pulmonary nodule in 2013
.
Diagn Interv Imaging
.
2013
;
94
(
11
):
1081
94
. .
6.
Jaklitsch
MT
,
Mery
CM
,
Audisio
RA
.
The use of surgery to treat lung cancer in elderly patients
.
Lancet Oncol
.
2003
;
4
(
8
):
463
71
. .
7.
Kramer
T
,
Annema
JT
.
Advanced bronchoscopic techniques for the diagnosis and treatment of peripheral lung cancer
.
Lung Cancer
.
2021
;
161
:
152
62
. .
8.
Steinfort
DP
,
Christie
M
,
Antippa
P
,
Rangamuwa
K
,
Padera
R
,
Müller
MR
, et al
.
Bronchoscopic thermal vapour ablation for localized cancer lesions of the lung: a clinical feasibility treat-and-resect study
.
Respiration
.
2021
;
100
(
5
):
432
42
. .
9.
Kniese
CM
,
Musani
AI
.
Bronchoscopic treatment of inoperable nonsmall cell lung cancer
.
Eur Respir Rev
.
2020
;
29
(
158
):
200035
. .
10.
Manyak
A
,
Seaburg
L
,
Bohreer
K
,
Kirtland
SH
,
Hubka
M
,
Gerbino
AJ
.
Invasive procedures associated with lung cancer screening in clinical practice
.
Chest
.
2023
;
164
(
2
):
544
55
. .
11.
Yankelevitz
DF
,
Yip
R
,
Henschke
CI
.
Impact of duration of diagnostic workup on prognosis for early lung cancer
.
J Thorac Oncol
.
2023
;
18
(
4
):
527
37
. .
12.
Rickets
W
,
Lau
KKW
,
Pollit
V
,
Mealing
S
,
Leonard
C
,
Mallender
P
, et al
.
Exploratory cost-effectiveness model of electromagnetic navigation bronchoscopy (ENB) compared with CT-guided biopsy (TTNA) for diagnosis of malignant indeterminate peripheral pulmonary nodules
.
BMJ Open Respir Res
.
2020
;
7
(
1
):
e000595
. .
13.
Altorki
N
,
Wang
X
,
Kozono
D
,
Watt
C
,
Landrenau
R
,
Wigle
D
, et al
.
Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer
.
N Engl J Med
.
2023
;
388
(
6
):
489
98
. .
14.
Tsutani
Y
,
Miyata
Y
,
Nakayama
H
,
Okumura
S
,
Adachi
S
,
Yoshimura
M
, et al
.
Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy
.
Chest
.
2014
;
145
(
1
):
66
71
. .
15.
Li
Y
,
Byun
AJ
,
Choe
JK
,
Lu
S
,
Restle
D
,
Eguchi
T
, et al
.
Micropapillary and solid histologic patterns in N1 and N2 lymph node metastases are independent factors of poor prognosis in patients with stages II to III lung adenocarcinoma
.
J Thorac Oncol
.
2023
;
18
(
5
):
608
19
. .
16.
Aokage
K
,
Suzuki
K
,
Saji
H
,
Wakabayashi
M
,
Kataoka
T
,
Sekino
Y
, et al
.
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial
.
Lancet Respir Med
.
2023
;
11
(
6
):
540
9
. .
17.
Kinj
R
,
Bourhis
J
.
How stereotactic radiotherapy changed the landscape in cancer care
.
Cancers
.
2023
;
15
(
6
):
1734
. .
18.
Das
A
,
Giuliani
M
,
Bezjak
A
.
Radiotherapy for lung metastases: conventional to stereotactic body radiation therapy
.
Semin Radiat Oncol
.
2023
;
33
(
2
):
172
80
. .
19.
Kroeze
SGC
,
Pavic
M
,
Stellamans
K
,
Lievens
Y
,
Becherini
C
,
Scorsetti
M
, et al
.
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium
.
Lancet Oncol
.
2023
;
24
(
3
):
e121
32
. .
20.
Korpics
MC
,
Onderdonk
BE
,
Dadey
RE
,
Hara
JH
,
Karapetyan
L
,
Zha
Y
, et al
.
Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases
.
J Clin Invest
.
2023
;
133
(
10
):
133
. .
21.
Takeda
A
,
Kunieda
E
,
Sanuki
N
,
Aoki
Y
,
Oku
Y
,
Handa
H
.
Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer
.
Lung Cancer
.
2012
;
77
(
1
):
77
82
. .
22.
Harris
K
,
Puchalski
J
,
Sterman
D
.
Recent advances in bronchoscopic treatment of peripheral lung cancers
.
Chest
.
2017
;
151
(
3
):
674
85
. .
23.
Chang
JY
,
Senan
S
,
Paul
MA
,
Mehran
RJ
,
Louie
AV
,
Balter
P
, et al
.
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
.
Lancet Oncol
.
2015
;
16
(
6
):
630
7
. .
24.
Chang
JY
,
Mehran
RJ
,
Feng
L
,
Verma
V
,
Liao
Z
,
Welsh
JW
, et al
.
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery
.
Lancet Oncol
.
2021
;
22
(
10
):
1448
57
. .
25.
Tual
A
,
Revel
MP
,
Canniff
E
,
Garin
A
,
Chassagnon
G
.
Risk of pleural and diaphragmatic complications following percutaneous radiofrequency ablation of basal lung nodules
.
Diagn Interv Imaging
.
2022
;
103
(
6
):
324
6
. .
26.
Huang
BY
,
Li
XM
,
Song
XY
,
Zhou
JJ
,
Shao
Z
,
Yu
ZQ
, et al
.
Long-term results of CT-guided percutaneous radiofrequency ablation of inoperable patients with stage Ia non-small cell lung cancer: a retrospective cohort study
.
Int J Surg
.
2018
;
53
:
143
50
. .
27.
Hasegawa
T
,
Takaki
H
,
Kodama
H
,
Yamanaka
T
,
Nakatsuka
A
,
Sato
Y
, et al
.
Three-year survival rate after radiofrequency ablation for surgically resectable colorectal lung metastases: a prospective multicenter study
.
Radiology
.
2020
;
294
(
3
):
686
95
. .
28.
Tselikas
L
,
Garzelli
L
,
Mercier
O
,
Auperin
A
,
Lamrani
L
,
Deschamps
F
, et al
.
Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease
.
Diagn Interv Imaging
.
2021
;
102
(
1
):
19
26
. .
29.
Yu
J
,
Cheng
ZG
,
Han
ZY
,
Liu
FY
,
Zheng
RQ
,
Cheng
W
, et al
.
Period-dependent survival benefit of percutaneous microwave ablation for hepatocellular carcinoma: a 12-year real-world, multicentric experience
.
Liver Cancer
.
2022
;
11
(
4
):
341
53
. .
30.
Zheng
L
,
Dou
JP
,
Han
ZY
,
Liu
FY
,
Yu
J
,
Cheng
ZG
, et al
.
Microwave ablation for papillary thyroid microcarcinoma with and without US-detected capsule invasion: a multicenter prospective cohort study
.
Radiology
.
2023
;
307
(
3
):
e220661
. .
31.
Cheng
PL
,
Wu
PH
,
Kao
WY
,
Lai
YT
,
Hsu
JC
,
Chiou
JF
, et al
.
Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis
.
Exp Hematol Oncol
.
2023
;
12
(
1
):
37
. .
32.
Aufranc
V
,
Farouil
G
,
Abdel-Rehim
M
,
Smadja
P
,
Tardieu
M
,
Aptel
S
, et al
.
Percutaneous thermal ablation of primary and secondary lung tumors: comparison between microwave and radiofrequency ablation
.
Diagn Interv Imaging
.
2019
;
100
(
12
):
781
91
. .
33.
Iezzi
R
,
Cioni
R
,
Basile
D
,
Tosoratti
N
,
Posa
A
,
Busso
M
, et al
.
Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study)
.
Eur Radiol
.
2021
;
31
(
4
):
2173
82
. .
34.
Huang
G
,
Yang
X
,
Li
W
,
Wang
J
,
Han
X
,
Wei
Z
, et al
.
A feasibility and safety study of computed tomography-guided percutaneous microwave ablation: a novel therapy for multiple synchronous ground-glass opacities of the lung
.
Int J Hyperthermia
.
2020
;
37
(
1
):
414
22
. .
35.
Yuan
Z
,
Wang
Y
,
Zhang
J
,
Zheng
J
,
Li
W
.
A meta-analysis of clinical outcomes after radiofrequency ablation and microwave ablation for lung cancer and pulmonary metastases
.
J Am Coll Radiol
.
2019
;
16
(
3
):
302
14
. .
36.
Tan
WP
,
Wysock
JS
,
Lepor
H
.
Partial gland cryoablation for prostate cancer: where are we
.
Nat Rev Urol
.
2023
;
20
(
3
):
127
8
. .
37.
Pusceddu
C
,
Mascia
L
,
Ninniri
C
,
Ballicu
N
,
Zedda
S
,
Melis
L
, et al
.
The increasing role of CT-guided cryoablation for the treatment of liver cancer: a single-center report
.
Cancers
.
2022
;
14
(
12
):
3018
. .
38.
Callstrom
MR
,
Woodrum
DA
,
Nichols
FC
,
Palussiere
J
,
Buy
X
,
Suh
RD
, et al
.
Multicenter study of metastatic lung tumors targeted by interventional cryoablation evaluation (SOLSTICE)
.
J Thorac Oncol
.
2020
;
15
(
7
):
1200
9
. .
39.
Nault
JC
,
Sutter
O
,
Nahon
P
,
Ganne-Carrié
N
,
Séror
O
.
Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations
.
J Hepatol
.
2018
;
68
(
4
):
783
97
. .
40.
Jahangeer
S
,
Forde
P
,
Soden
D
,
Hinchion
J
.
Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours
.
Cancer Treat Rev
.
2013
;
39
(
8
):
862
71
. .
41.
Palussière
J
,
Cazayus
M
,
Cousin
S
,
Cabart
M
,
Chomy
F
,
Catena
V
, et al
.
Is there a role for percutaneous ablation for early stage lung cancer? What is the evidence
.
Curr Oncol Rep
.
2021
;
23
(
7
):
81
. .
42.
Scarlata
S
,
Fuso
L
,
Lucantoni
G
,
Varone
F
,
Magnini
D
,
Antonelli Incalzi
R
, et al
.
The technique of endoscopic airway tumor treatment
.
J Thorac Dis
.
2017
;
9
(
8
):
2619
39
. .
43.
Vieira
T
,
Stern
JB
,
Girard
P
,
Caliandro
R
.
Endobronchial treatment of peripheral tumors: ongoing development and perspectives
.
J Thorac Dis
.
2018
;
10
(
Suppl 10
):
S1163
7
. .
44.
Zheng
X
,
Yuan
H
,
Gu
C
,
Yang
C
,
Xie
F
,
Zhang
X
, et al
.
Transbronchial lung parenchyma cryoablation with a novel flexible cryoprobe in an in vivo porcine model
.
Diagn Interv Imaging
.
2022
;
103
(
1
):
49
57
. .
45.
Steinfort
DP
,
Herth
FJF
.
Bronchoscopic treatments for early-stage peripheral lung cancer: are we ready for prime time
.
Respirology
.
2020
;
25
(
9
):
944
52
. .
46.
Yuan
HB
,
Wang
XY
,
Sun
JY
,
Xie
FF
,
Zheng
XX
,
Tao
GY
, et al
.
Flexible bronchoscopy-guided microwave ablation in peripheral porcine lung: a new minimally-invasive ablation
.
Transl Lung Cancer Res
.
2019
;
8
(
6
):
787
96
. .
47.
Bolliger
CT
,
Mathur
PN
,
Beamis
JF
,
Becker
HD
,
Cavaliere
S
,
Colt
H
, et al
.
ERS/ATS statement on interventional pulmonology. European respiratory society/American thoracic society
.
Eur Respir J
.
2002
;
19
(
2
):
356
73
. .
48.
Kobayashi
T
,
Kaneko
M
,
Sumi
M
,
Kubota
K
,
Kondo
H
.
CT-assisted transbronchial brachytherapy for small peripheral lung cancer
.
Jpn J Clin Oncol
.
2000
;
30
(
2
):
109
12
. .
49.
Harms
W
,
Krempien
R
,
Grehn
C
,
Hensley
F
,
Debus
J
,
Becker
HD
.
Electromagnetically navigated brachytherapy as a new treatment option for peripheral pulmonary tumors
.
Strahlenther Onkol
.
2006
;
182
(
2
):
108
11
. .
50.
Fernando
HC
.
Radiofrequency ablation to treat non-small cell lung cancer and pulmonary metastases
.
Ann Thorac Surg
.
2008
;
85
(
2
):
S780
784
. .
51.
Belfiore
G
,
Ronza
F
,
Belfiore
MP
,
Serao
N
,
di Ronza
G
,
Grassi
R
, et al
.
Patients’ survival in lung malignancies treated by microwave ablation: our experience on 56 patients
.
Eur J Radiol
.
2013
;
82
(
1
):
177
81
. .
52.
Hiraki
T
,
Gobara
H
,
Iishi
T
,
Sano
Y
,
Iguchi
T
,
Fujiwara
H
, et al
.
Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates
.
J Thorac Cardiovasc Surg
.
2007
;
134
(
5
):
1306
12
. .
53.
Tanabe
T
,
Koizumi
T
,
Tsushima
K
,
Ito
M
,
Kanda
S
,
Kobayashi
T
, et al
.
Comparative study of three different catheters for CT imaging-bronchoscopy-guided radiofrequency ablation as a potential and novel interventional therapy for lung cancer
.
Chest
.
2010
;
137
(
4
):
890
7
. .
54.
Sun
J
,
Criner
GJ
,
Dibardino
D
,
Li
S
,
Nader
D
,
Lam
B
, et al
.
Efficacy and safety of virtual bronchoscopic navigation with fused fluoroscopy and vessel mapping for access of pulmonary lesions
.
Respirology
.
2022
;
27
(
5
):
357
65
. .
55.
Chen
AC
,
Pastis
NJ
Jr
,
Mahajan
AK
,
Khandhar
SJ
,
Simoff
MJ
,
Machuzak
MS
, et al
.
Robotic bronchoscopy for peripheral pulmonary lesions: a multicenter pilot and feasibility study (BENEFIT)
.
Chest
.
2021
;
159
(
2
):
845
52
. .
56.
Kalchiem-Dekel
O
,
Connolly
JG
,
Lin
IH
,
Husta
BC
,
Adusumilli
PS
,
Beattie
JA
, et al
.
Shape-Sensing robotic-assisted bronchoscopy in the diagnosis of pulmonary parenchymal lesions
.
Chest
.
2022
;
161
(
2
):
572
82
. .
57.
Reisenauer
J
,
Simoff
MJ
,
Pritchett
MA
,
Ost
DE
,
Majid
A
,
Keyes
C
, et al
.
Ion: technology and techniques for shape-sensing robotic-assisted bronchoscopy
.
Ann Thorac Surg
.
2022
;
113
(
1
):
308
15
. .
58.
Thiboutot
J
,
Argento
AC
,
Akulian
J
,
Lee
HJ
,
DeMaio
A
,
Kapp
CM
, et al
.
Accuracy of pulmonary nodule sampling using robotic assisted bronchoscopy with shape sensing, fluoroscopy, and radial endobronchial ultrasound (the ACCURACY study)
.
Respiration
.
2022
;
101
(
5
):
485
93
. .
59.
Xiang
ZJ
,
Wang
Y
,
Du
EF
,
Xu
L
,
Jiang
B
,
Li
H
, et al
.
The value of Cone-Beam CT-guided radiofrequency ablation in the treatment of pulmonary malignancies (≤3 cm)
.
Biosci Rep
.
2019
;
39
(
2
):
BSR20181230
. .
60.
Zhong
CH
,
Su
ZQ
,
Luo
WZ
,
Rao
WY
,
Feng
JX
,
Tang
CL
, et al
.
Hierarchical clock-scale hand-drawn mapping as a simple method for bronchoscopic navigation in peripheral pulmonary nodule
.
Respir Res
.
2022
;
23
(
1
):
245
. .
61.
Tian
Y
,
Qi
X
,
Jiang
X
,
Shang
L
,
Xu
K
,
Shao
H
.
Cryoablation and immune synergistic effect for lung cancer: a review
.
Front Immunol
.
2022
;
13
:
950921
. .
62.
Aarts
BM
,
Klompenhouwer
EG
,
Rice
SL
,
Imani
F
,
Baetens
T
,
Bex
A
, et al
.
Cryoablation and immunotherapy: an overview of evidence on its synergy
.
Insights Imaging
.
2019
;
10
(
1
):
53
. .
You do not currently have access to this content.